Last 12 months
Inside the activity.
0 purchase rows · 204 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 17 |
| Dec 2025 | 0 | 26 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 32 |
| Jul 2026 | 0 | 64 |
| Aug 2026 | 0 | 27 |
| Sep 2026 | 0 | 20 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 09, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 300 | $367.10 | $110,129.82 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 21 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $367.04 to $367.21, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 200 | $365.93 | $73,185.00 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 20 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 485 | $364.19 | $176,632.88 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 19 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.81 to $364.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 449 | $363.15 | $163,055.56 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 18 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,585 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.71 to $363.68, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 300 | $361.56 | $108,468.99 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 17 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,034 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $361.38 to $361.655, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 200 | $359.97 | $71,993.00 |
DisclosureSEC source: 0001651308-21-000226 · wf-form4_163658341717636.xml · nonDerivative · entry 19 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.94 to $359.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 100 | $358.67 | $35,867.00 |
DisclosureSEC source: 0001651308-21-000226 · wf-form4_163658341717636.xml · nonDerivative · entry 18 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 200 | $358.20 | $71,640.68 |
DisclosureSEC source: 0001651308-21-000226 · wf-form4_163658341717636.xml · nonDerivative · entry 17 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.66 to $358.59, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 300 | $355.12 | $106,536.99 |
DisclosureSEC source: 0001651308-21-000226 · wf-form4_163658341717636.xml · nonDerivative · entry 16 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.87 to $355.59, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 500 | $354.05 | $177,026.00 |
DisclosureSEC source: 0001651308-21-000226 · wf-form4_163658341717636.xml · nonDerivative · entry 15 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.82 to $354.28, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 200 | $353.13 | $70,626.00 |
DisclosureSEC source: 0001651308-21-000226 · wf-form4_163658341717636.xml · nonDerivative · entry 14 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.76 to $353.50, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 300 | $351.28 | $105,383.01 |
DisclosureSEC source: 0001651308-21-000226 · wf-form4_163658341717636.xml · nonDerivative · entry 13 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.13 to $351.57, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 98 | $349.93 | $34,293.14 |
DisclosureSEC source: 0001651308-21-000226 · wf-form4_163658341717636.xml · nonDerivative · entry 12 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 700 | $348.82 | $244,176.03 |
DisclosureSEC source: 0001651308-21-000226 · wf-form4_163658341717636.xml · nonDerivative · entry 11 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,898 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.39 to $349.36, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 402 | $347.71 | $139,781.19 |
DisclosureSEC source: 0001651308-21-000226 · wf-form4_163658341717636.xml · nonDerivative · entry 10 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,598 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $347.36 to $348.25, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 700 | $346.81 | $242,764.97 |
DisclosureSEC source: 0001651308-21-000226 · wf-form4_163658341717636.xml · nonDerivative · entry 9 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $346.20 to $347.15, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 300 | $344.96 | $103,488.99 |
DisclosureSEC source: 0001651308-21-000226 · wf-form4_163658341717636.xml · nonDerivative · entry 8 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,700 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.86 to $345.02, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 100 | $343.84 | $34,384.00 |
DisclosureSEC source: 0001651308-21-000226 · wf-form4_163658341717636.xml · nonDerivative · entry 7 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 400 | $343.10 | $137,241.00 |
DisclosureSEC source: 0001651308-21-000226 · wf-form4_163658341717636.xml · nonDerivative · entry 6 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,100 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.79 to $343.75, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 100 | $361.03 | $36,103.00 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 16 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 4,433 | $360.08 | $1,596,221.78 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 15 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.94 to $360.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 200 | $358.59 | $71,718.00 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 14 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,533 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 300 | $355.32 | $106,595.01 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 13 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,733 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.92 to $355.59, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 300 | $354.03 | $106,208.01 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 12 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,033 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.92 to $354.20, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 100 | $352.76 | $35,276.00 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 11 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,333 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 300 | $351.28 | $105,383.01 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 10 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,433 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.13 to $351.57, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 164 | $349.66 | $57,344.26 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 9 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,733 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.36 to $350.27, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 449 | $348.70 | $156,567.11 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 8 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,897 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.25 to $348.90, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 420 | $347.20 | $145,826.02 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 7 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,346 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $347.05 to $347.38, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 300 | $346.43 | $103,929.00 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,766 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $346.05 to $347.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 300 | $345.06 | $103,518.99 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,066 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.01 to $345.17, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 300 | $343.12 | $102,935.01 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,366 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.80 to $343.75, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:25 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 200 | $359.97 | $71,993.00 |
DisclosureSEC source: 0001651308-21-000225 · wf-form4_163658309940308.xml · nonDerivative · entry 18 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.94 to $359.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:25 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 100 | $357.25 | $35,724.58 |
DisclosureSEC source: 0001651308-21-000225 · wf-form4_163658309940308.xml · nonDerivative · entry 17 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.24 to $357.82, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:25 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 308 | $355.15 | $109,385.80 |
DisclosureSEC source: 0001651308-21-000225 · wf-form4_163658309940308.xml · nonDerivative · entry 16 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.91 to $355.74, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:25 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 677 | $354.18 | $239,778.44 |
DisclosureSEC source: 0001651308-21-000225 · wf-form4_163658309940308.xml · nonDerivative · entry 15 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.82 to $354.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:25 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 200 | $353.13 | $70,626.00 |
DisclosureSEC source: 0001651308-21-000225 · wf-form4_163658309940308.xml · nonDerivative · entry 14 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,285 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.76 to $353.50, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:25 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 300 | $351.28 | $105,383.01 |
DisclosureSEC source: 0001651308-21-000225 · wf-form4_163658309940308.xml · nonDerivative · entry 13 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,485 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.13 to $351.57, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:25 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 38 | $349.94 | $13,297.79 |
DisclosureSEC source: 0001651308-21-000225 · wf-form4_163658309940308.xml · nonDerivative · entry 12 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,785 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.83 to $350.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:25 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 662 | $348.89 | $230,967.50 |
DisclosureSEC source: 0001651308-21-000225 · wf-form4_163658309940308.xml · nonDerivative · entry 11 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,823 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.50 to $349.36, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:25 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 440 | $348.03 | $153,131.44 |
DisclosureSEC source: 0001651308-21-000225 · wf-form4_163658309940308.xml · nonDerivative · entry 10 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,485 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $347.45 to $348.37, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:25 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 775 | $346.83 | $268,790.54 |
DisclosureSEC source: 0001651308-21-000225 · wf-form4_163658309940308.xml · nonDerivative · entry 9 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,925 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $346.24 to $347.15, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:25 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 300 | $344.96 | $103,488.99 |
DisclosureSEC source: 0001651308-21-000225 · wf-form4_163658309940308.xml · nonDerivative · entry 8 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,700 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.86 to $345.02, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:25 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 200 | $343.84 | $68,768.00 |
DisclosureSEC source: 0001651308-21-000225 · wf-form4_163658309940308.xml · nonDerivative · entry 7 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:25 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 300 | $342.71 | $102,813.00 |
DisclosureSEC source: 0001651308-21-000225 · wf-form4_163658309940308.xml · nonDerivative · entry 6 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,200 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2021. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.52 to $342.80, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| October 31, 2021 Filed Dec 17, 2021 22:05 UTC |
Wang LaiGlobal Head of R&D
|
GiftOrdinary Shares | 58,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-21-000263 · wf-form4_163977871142348.xml · nonDerivative · entry 3 Wang Lai · CIK 0001852291 · Global Head of R&D 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 58,188 F4 · ownership.nature: These securities are held by Wang Holdings LLC, the limited liability company interests of which are owned by the Reporting Person, his spouse and a trust created by the Reporting Person for the benefit of his spouse and children, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| October 31, 2021 Filed Dec 17, 2021 22:05 UTC |
Wang LaiGlobal Head of R&D
|
GiftOrdinary Shares | 58,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-21-000263 · wf-form4_163977871142348.xml · nonDerivative · entry 2 Wang Lai · CIK 0001852291 · Global Head of R&D 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F2 · kind: Bona fide gift of the limited liability company interest which is exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5. F3 · ownership.nature: These securities are held by Wang Holdings LLC, which is owned by the Reporting Person and his spouse. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 21:37 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0001651308-21-000209 · wf-form4_163485223713937.xml · derivative · entry 10 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,276 Underlying: Ordinary Shares · 19,500 shares Expires 2029-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. F8 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 21:37 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 100 | $377.71 | $37,771.00 |
DisclosureSEC source: 0001651308-21-000209 · wf-form4_163485223713937.xml · nonDerivative · entry 9 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 21:37 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 200 | $376.36 | $75,272.00 |
DisclosureSEC source: 0001651308-21-000209 · wf-form4_163485223713937.xml · nonDerivative · entry 8 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $375.89 to $376.83, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.